id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-E-2617-0001,FDA,FDA-2018-E-2617,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2018-09-18T04:00:00Z,2018,9,2018-09-18T04:00:00Z,,2018-09-18T18:25:57Z,,0,0,0900006483716759